Marissa Brittenham insider trades: Surgery Partners (SGRY) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Marissa reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | SGRY | ↓ Sell | 3,657 | $12.54 | $46K | Direct | Mar 16, 2026 (3d) |
| Mar 6, 2026 | SGRY | ↓ Sell | 8,785 | $13.70 | $120K | Direct | Mar 9, 2026 (3d) |
| Mar 10, 2025 | SGRY | ↓ Sell | 3,156 | $24.09 | $76K | Direct | Mar 13, 2025 (3d) |
| Feb 7, 2025 | SGRY | ↓ Sell | 14,700 | $25.61 | $376K | Direct | Feb 10, 2025 (3d) |
| Mar 4, 2024 | SGRY | ↓ Sell | 1,284 | $30.17 | $39K | Direct | Mar 6, 2024 (2d) |
| Feb 2, 2024 | SGRY | ↓ Sell | 1,637 | $31.89 | $52K | Direct | Feb 6, 2024 (4d) |
| Feb 2, 2023 | SGRY | ↓ Sell | 1,320 | $35.90 | $47K | Direct | Feb 6, 2023 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SGRY insiders
Open-market trades in the last 12 months
About Marissa Brittenham's insider trades
Marissa Brittenham is Chief Strategy Officer at Surgery Partners (SGRY). Since Feb 2, 2023, Marissa has reported no open-market purchases and 7 sales worth $757K on SEC Form 4. In the last 12 months: 2 sales ($166K).
Their filings also include grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SGRY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.